In contrast, Eaton et al. showed that patients with NAFLD had a significantly increased amount of 3-hydroxyacyl-CoA and 2-enoyl-CoA esters in their liver mitochondria, suggesting a decreased HADHA activity [37]. The gene discussed is HADHA; the disease is metabolic dysfunction-associated steatotic liver disease.